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The trophoblast cell lineage is an interesting model system because it is composed of a limited number of cell types that are spatially
patterned. Trophoblast stem (TS) cells reside within a layer called the chorion and either remain as stem cells or differentiate into
spongiotrophoblast (SpT), trophoblast giant (TG) cells or syncytiotrophoblast cells (SynT) of the labyrinth. Maintenance of the TS phenotype
is dependent on stimulation by FGF4, whereas differentiation and/or maintenance of the differentiated derivatives are dependent on key
transcription factors: Mash2 for SpT, Hand1 for TG cells and Gcm1 for SynT cells. TS cells proliferate and retain their stem cell phenotype in
culture in response to FGF4 and an additional factor(s) that can be provided by conditioned medium from embryonic fibroblast feeder cells
(CM). To understand the functions of Hand1, Mash2 and Gcm1 at a cellular level, we tested the effects of their ectopic and over-expression
on the ability of TS cells to either continue to proliferate or differentiate into their alternative fates. Expression of Mash2 alone had no effects
on TS cell differentiation. However, Mash2-transfected cells continued to divide longer after withdrawal of FGF/CM. Hand1 promoted TGC
differentiation, even in the continued presence of FGF4/CM. Stra13, another bHLH factor gene that is expressed in TG cells, also induced
TG differentiation. Gcm1 induced a rapid arrest of TS proliferation but, in contrast to Hand1 and Stra13, blocked TG cell differentiation.
Although Gcm1 was not sufficient to promote SynT formation, expression of an antisense Gcm1 transcript blocked SynT differentiation.
These data suggest that Mash2 functions to promote transient FGF4-independent amplification of trophoblast cells that are progressing
towards the SpT and TG cell phenotype. By contrast, Hand1 and Stra13 promote cell cycle exit and restrict cells towards the TG fate,
whereas Gcm1 promotes cell cycle exit and restriction towards the SynT fate.
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USA.The trophoblast cell lineage is specified at the blastocyst
stage of development and contributes exclusively to the
epithelial compartment of the placenta. The cell lineage is
relatively simple in that there are only four major differen-
tiated cell types that can be derived from trophoblast stem
(TS) cells in mice: trophoblast giant cells (TG), spongiotro-
phoblast (SpT), syncytiotrophoblast (SynT) and glycogen
trophoblast cells (GlyT) (Cross et al., 2002b; Rossant and
Cross, 2001). TG cells are large polyploid cells that appear
soon after embryo implantation and mediate invasion into
M. Hughes et al. / Developmental Biology 271 (2004) 26–37 27the uterus and also promote local and systemic adaptations in
the mother that are necessary for embryonic growth and
survival (Cross et al., 1994, 2002c). A subtype of TG cells
invades into the maternal spiral arteries that bring blood to
the implantation site (Adamson et al., 2002). The SpT layer
forms the middle part of the placenta between the outermost
giant cells and the innermost labyrinth layer. It probably has
a structural role but in addition, SpT cells produce some
unique secreted proteins and are also precursors of TG cells
and GlyT cells (Rossant, 1995). GlyT cells have an unknown
function but they appear only late in gestation, first within
the SpT layer and later they invade diffusely into the
interstitium of the uterus (Adamson et al., 2002). SynT cells
are multi-nucleated cells that form as a result of cell–cell
fusion and function as the major transport surface for nutrient
and gas exchange between the maternal and fetal circulation
in the villous part of the placenta (called the labyrinth in
mice) (Cross, 2000; Cross et al., 2002a).
Genetic studies in mice have revealed the major pathways
controlling development of the trophoblast cell lineage. The
maintenance of TS cells in the early embryo is dependent on
FGF signaling involving the ligand FGF4 (Feldman et al.,
1995), the FGFR2 receptor (Arman et al., 1998) and the
downstream transcription factors Cdx2 and Eomes (for
review, see Rossant and Cross, 2001). The orphan nuclear
receptor Err2 is required for stem cell maintenance at a
slightly later stage (Luo et al., 1997; Tremblay et al., 2001).
The formation and/or maintenance of the major differentiat-
ed trophoblast subtypes can be traced to transcription factor
pathways that ultimately regulate cell fate decisions. The
formation of TG cells is dependent on Hand1, a member of
the basic helix-loop-helix (bHLH) transcription factor family
(Riley et al., 1998; Scott et al., 2000). Another bHLH factor,
Mash2, is essential for maintaining SpT cells, as in its
absence, the SpT layer is lost and more TG cells form
(Guillemot et al., 1994; Tanaka et al., 1997). Consistent with
the later finding, over-expression of Mash2 in Rcho-1 cells, a
rat trophoblast tumor (choriocarcinoma) cell line, prevents
TG cell differentiation (Cross et al., 1995; Kraut et al., 1998;
Scott et al., 2000). Other bHLH factors are implicated in
trophoblast development based on specific expression pat-
terns. Stra13 mRNA expression has been suggested in TG
cells in mice, though not well documented (Boudjelal et al.,
1997), and the dominant-negative HLH factor Id2 is
expressed in the TS cell compartment (Jen et al., 1997).
Regulated expression of STRA13 and ID2 in the human
placenta is consistent with potential roles in trophoblast
differentiation (Janatpour et al., 1999, 2000). No bHLH
factors have been implicated in SynT differentiation. How-
ever, the formation of SynT cells is dependent on a distinct
type of transcription factor called Gcm1 (Anson-Cartwright
et al., 2000).
Although it is clear from the studies to date that key
transcription factors are required for formation and/or main-
tenance of differentiated trophoblast subtypes, it is unclear
how their activities are controlled and coordinated with thesignals that regulate the maintenance of the TS cell pheno-
type. One of the interesting features of the trophoblast
lineage is that early after implantation, the TS cell popula-
tion is restricted to a discrete compartment called the
chorion (also called extraembryonic ectoderm) (Rossant
and Cross, 2001; Uy et al., 2002). In situ hybridization
studies have failed to detect Hand1 mRNA in the chorion
(Cross et al., 1995; Scott et al., 2000), although expression
from a LacZ ‘knock in’ reporter can be detected (Firulli et
al., 1998), implying that Hand1 transcription is either very
low and/or that the transcript is unstable in chorionic
trophoblast cells. Gcm1 mRNA expression is limited to
only those specific cells that are selected out to contribute
to the labyrinth and differentiate into SynT cells (Anson-
Cartwright et al., 2000; Stecca et al., 2002). Mash2 mRNA
is expressed in the chorion, but also in the ectoplacental
cone (which later becomes the SpT layer) (Guillemot et al.,
1994; Nakayama et al., 1997). These data suggest that
suppressing the expression of these differentiating transcrip-
tion factors in the chorion may be essential for the mainte-
nance of TS cells. Rcho-1 cells have been previously used to
test the effect of ectopic expression of Hand1 and Mash2 on
TG cell differentiation (Cross et al., 1995; Kraut et al., 1998;
Scott et al., 2000). However, these cells cannot be regulated
in the same way as TS cells, nor do they develop into the
diverse range of differentiated cell types. For this reason, we
conducted studies using a murine TS cell line in which the
differentiation potential of the cells is modulated by culture
in the presence or absence of FGF4 (Tanaka et al., 1998).
We found that ectopic expression of Hand1, Stra13 and
Gcm1 were able to arrest cell proliferation and promote
differentiation even when the cells were maintained in
FGF4. Mash2 had no significant effect on the behavior of
TS cells in the presence of FGF4, but promoted transient
proliferation after FGF4 withdrawal.Materials and methods
Plasmids
For TS cell transfection experiments, the cDNAs for
Hand1, Mash2 and Gcm1 were subcloned in the sense
orientation into the pTRACER plasmid (Invitrogen) down-
stream of the CMV promoter/enhancer. The full-length
Gcm1 cDNAwas also subcloned in an antisense orientation
that was used for some experiments. The plasmid also
carries an EF-1a promoter driving expression of a GFP/
blasticidin fusion protein that allows detection of transfected
cells by visualization of GFP. The Stra13 expression vector
(pSG5-STRA13) was obtained from Dr. Pierre Chambon
(Strasbourg), and was co-transfected into TS cells together
with the empty pTRACER vector (ratio of 5:1). CMV
expression vectors for Hand1 and Mash2, used for the
Rcho-1 experiments, have been previously described (Cross
et al., 1995; Scott et al., 2000).
Fig. 1. Expression of Hand1, Mash2, Gcm1 and Stra13 mRNAs during TS
cell differentiation. Total RNA was collected from TS cells maintained in
the presence of FGF4/CM (time 0) or at different days after withdrawal of
FGF4/CM and analyzed by Northern blotting. Pl1 is a TG cell-specific
gene.
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ATS cell line derived from Rosa26 mice was used for all
experiments (from Dr. Janet Rossant, Toronto) and was
maintained as described previously (Tanaka et al., 1998).
Briefly, the cells were grown in medium supplemented with
25 ng/ml FGF4 (Sigma Chemical Company) and 70%
conditioned medium from mouse embryonic fibroblasts
(CM). To promote differentiation, the growth medium was
removed, the cells were washed once with phosphate-
buffered saline and re-fed with medium lacking the FGF4
and CM. Cells seeded in six-well plates were transfected
with Lipofectamine using a total of 4 Ag of plasmid per well.
Rcho-1 cells were grown and transfected as described
previously (Cross et al., 1995; Scott et al., 2000). For cell
differentiation experiments, transfected cells were plated at
low density (1:50) and observed for up to 72 h. Transfected
cells were detected by their expression of EGFP, scored for
morphology, and their ability to proliferate was based on the
emergence of a multi-cell clone. Fifty to one hundred clones
were assessed for each transfection group, and experiments
were repeated two to three times.
RNA analysis
Total RNA was isolated from TS cells using TRIzolR
(Invitrogen) and 10 Ag per sample was analyzed by North-
ern blotting. Complementary DNA probes for Gcm1 (Alt-
shuller et al., 1996), Mash2 (Guillemot et al., 1994), Stra13
(Boudjelal et al., 1997), Hand1 (Cross et al., 1995) and Pl1
(Colosi et al., 1987) have been described previously. North-
ern blots were quantitated by densitometry using NIH Image
1.62 on scanned blots, and signals were normalized for
loading by using an 18S rRNA probe. Two identical blots
were prepared to deal with all of the different probes. In situ
hybridization was performed on paraffin sections of con-
ceptuses in deciduo from embryonic day 8.5 using nonra-
dioactive RNA in situ hybridization as described previously
(Anson-Cartwright et al., 2000).
Antibodies, Western blotting and immunostaining
An affinity-purified rabbit polyclonal antibody was made
against a Stra13-specific peptide (ELEKGDLRSEQ-
PYFKSDH) by Research Genetics Inc., and has been previ-
ously described (St-Pierre et al., 2002). Cell lysates from TS
cells or their differentiated derivatives were analyzed by
Western blotting using standard procedures. A mouse mono-
clonal antibody against Stra13 was prepared by the labora-
tory of Dr. Paul Hamel (Department of Laboratory Medicine
and Pathobiology, University of Toronto) by immunizing
mice against a GST-Stra13 fusion protein. Stra13-specific
antibodies were selected byWestern blot analysis for specific
recognition of HIS-Stra13 in Dr. Hamel’s laboratory. To
assess the specificity of the monoclonal antibody, COS-7
cells were transfected with pcDNA3, pcDNA3-Stra13 or
M. Hughes et al. / Developm28pcDNA3-FLAG-Stra13 using Qiagen Superfect reagent,
then lysed 36–48 h post-transfection. The presence of
ectopically expressed Stra13 in soluble protein lysate was
detected by Western blot using rabbit polyclonal anti-Stra13,
mouse monoclonal anti-Stra13 or mouse monoclonal anti-
FLAG (M2 antibody from Sigma).
Immunoperoxidase staining was performed on 4% para-
formaldehyde-fixed monolayers of differentiated cells de-
rived from TS cell cultures, using the Stra13 monoclonal
antibody. Dual immunofluorescent staining for Hand1 and
Stra13 was performed using a rabbit anti-Hand1 (Firulli et
al., 2003) and the mouse anti-Stra13 antibodies. TS cells
were differentiated in ‘TS cell medium’ lacking FGF/CM for
5 days before immunostaining. Cells were then fixed with
cold 4% paraformaldehyde, and permeabilized with metha-
nol and then 0.5% Triton X-100 in PBS on ice. The cells
were double stained with rabbit anti-Hand1 antiserum (pro-
vided by Dr. Cserjesi) and mouse anti-Stra 13 monoclonal
antibody for either overnight at 4 jC or 1 h at room
temperature, followed by the staining with Alexa FluorR
488-conjugated goat anti-rabbit IgG (Molecular Probes) and
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esearch) for 1 h at room temperature. The cells were counter-
stained with DAPI and then scored for immunoreactivity
(n = 245).Results
Expression of Gcm1, Hand1, Mash2 and Stra13 during
trophoblast differentiation
We performed Northern blots to assess the expression
of Hand1, Mash2 and Gcm1 in cultured TS cells before
and after differentiation. TS cells that are cultured in the
presence of FGF4 and conditioned medium from feeder
cells (CM) retain characteristics of TS cells in vivo, but
after withdrawal of FGF4/CM differentiate primarily into
TG cells (Tanaka et al., 1998). We collected RNA from
cells at various days after withdrawal of FGF4/CM (Fig.
1). The onset of Pl1 gene expression, which is specific to
TG cells (Colosi et al., 1987), was detectable only after
day 4 of differentiation (Fig. 1). The mRNAs for Hand1,
Mash2 and Gcm1 were expressed at either low (Gcm1,
Hand1) or undetectable (Mash2) levels in undifferentiated
TS cells but were readily detectable within 24 h after
withdrawal of FGF4/CM (Fig. 1). Weak expression of
these genes in undifferentiated cells may be explained by
the fact that a few differentiated derivatives always appear
in TS cell cultures, even under optimal stem cell growth
conditions (see Fig. 3). After withdrawal of FGF4/CM, theFig. 2. Expression of the Stra13 protein in TG cells. (A) Characterization of the S
Stra13 or FLAG-epitope tagged Stra13, or empty vector as negative control were im
or anti-FLAG antibodies. (B) Western blot of cell lysates from TS cells and their dif
TS cells grown on coverslips and differentiated for 5 days were fixed and pro
monoclonal (C) or control hybridoma supernatant (D). Arrowhead denotes immun
TS cells dual stained with anti-Hand1 and anti-Stra13 antibodies. Cells were sco
Hand1 (h), Stra13 (s), or both (sh).expression of Gcm1 mRNA increased approximately 12-
fold to peak around day 2, declined by day 3 and was
undetectable after day 6 (Fig. 1). The expression pattern
for Mash2 was similar except that the decline was less
precipitous. Expression of Hand1 mRNA was high
throughout the differentiation time course (Fig. 1), consis-
tent with its expression in both ectoplacental cone and TG
cells in vivo (Cross et al., 1995; Firulli et al., 1998; Scott
et al., 2000), though expression did decline about 3-fold
between days 2 and 8 of differentiation.
In addition to Hand1, Mash2 and Gcm1, we also
studied the expression of Stra13, a gene encoding a bHLH
transcription factor. Expression of this gene has been
described in the human placenta, with expression increas-
ing as cytotrophoblast cells differentiate into invasive
extravillous cytotrophoblast cells (Janatpour et al., 1999).
Stra13 expression in the mouse placenta has been only
crudely described (Boudjelal et al., 1997). During TS cell
differentiation in vitro, Stra13 mRNA was detectable only
after withdrawal of FGF4, increased to a peak around day
5 of differentiation and remained detectable thereafter (Fig.
1). This pattern was consistent with expression in TG cells
but potentially also in precursor cells. To localize the
mRNA expression, we first performed RNA in situ hy-
bridization on tissue sections, but Stra13 expression was
only weakly detected (data not shown). We therefore used
immunostaining with two independent Stra13-specific anti-
bodies. Both antibodies recognize an approximately 45-
kDa band in cell lysates similar to the size of the predicted
protein (Fig. 2A). The Stra13 protein was up-regulatedtra13 monoclonal antibody. Cell lysates from COS-7 cells transfected with
munoblotted with either the rabbit polyclonal antibody, mouse monoclonal
ferentiated derivatives at various days after withdrawal of FGF4/CM. (C, D)
cessed for immunoperoxidase staining using either the mouse anti-Stra13
opositive and asterisk indicates an immunonegative cells. (E) Differentiated
red for staining and counted as either immunonegative (), or positive for
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regulated similar to the mRNA (Fig. 2B). Stra13 immu-
noreactivity was detected in TG cells derived from the
differentiation of cultured TS cells (Fig. 2C). We found
that the Stra13 protein was localized in the nucleus, as
would be expected for a transcription factor, but was only
detected in <50% of the cells. The distinct patterns of
localization may relate to the fact that Stra13 protein levels
are regulated by the Vhl and UBC9/ubiquitin proteasome
degradation pathway (Ivanova et al., 2001). To determine
how the expression of the Stra13 protein compared with
Hand1, we performed dual immunofluorescence analysis
on monolayers of TS cells that had been allowed to
differentiate in the absence of FGF4/CM for 5 days (Fig.
2E). By 5 days of differentiation, the majority of cells in
the culture are polyploid, but only cells that had a typical
TG cell morphology (expansive flat cytoplasm, extensive
ER and large nucleus) were scored for expression. We
detected Stra13 immunoreactivity in only 30.8% of TG
cells, compared with 62.4% of cells that were immuno-Fig. 3. Differentiation of TS cells in vitro. (A) Morphology of TS cells and the
differentiation. Cells were plated at low density in either the presence or absence o
scoring cells under 200 magnification. Fifty to one hundred fields were countepositive for Hand1. The Stra13-positive cells were a subset
of the Hand1-positive cells, as 96% of the Stra13-postive
TG cells were also positive for Hand1, whereas only 47%
of Hand1-positive cells were also immunopositive for
Stra13. Roughly a third (36.9%) of the TG cells failed to
stain with either antibody.
Trophoblast stem cells differentiate into both giant cells and
syncytiotrophoblast after FGF4 withdrawal
Before studying the effect of altering the expression
patterns for Hand1, Mash2, Gcm1 and Stra13 on the
developmental potential of TS cells, we first quantified
the normal changes in cell populations as TS cells differ-
entiate in vitro. TS, TG and SynT cells have distinct cell
morphologies that can be readily distinguished in vitro
(Fig. 3A). TS cells are cuboidal and have a large nucleus-
to-cytoplasmic ratio. TG cells have a large expansive
cytoplasm and large polyploid nuclei. SynT cells have
multiple nuclei (usually only two in vitro) and moreir differentiated cell derivatives. (B) Time course of trophoblast stem cell
f FGF4/CM and the relative proportions of each cell type were assessed by
d for each time point. Plotted values represent mean F SEM.
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is similar to that of TS cells, consistent with them
remaining diploid. When cultures of TS cells are trypsi-
nized briefly, the differentiated cell types are more resistant
and remain attached to the dish. Therefore, by re-plating
only trypsin-sensitive cells, one starts with a relatively
homogeneous group of stem cells. To assess the time
course of cell differentiation, we plated trypsin-sensitive
TS cells at low density (1:20) and then counted the
numbers of cells conforming to the three primary cell
morphologies in TS cell cultures either left growing in
the presence of FGF4/CM, or following their withdrawal
(Fig. 3B). We found that within 48 h of FGF4/CM
withdrawal, the numbers of TG and SynT cells increased
significantly compared with cells remaining in FGF4/CM
(P < 0.05). Notably, approximately 50% of the cells had
transformed into TG cells, whereas the number of SynT
cells never reached levels above approximately 5%. With-
drawal of FGF4/CM is associated with cell division arrest
(Tanaka et al., 1998), but no obvious increase in cell death,
indicating that the increase in relative numbers of TG and
SynT cells reflects a true increase in cell differentiation and
not simply a loss of stem cells.Fig. 4. Effect of Mash2 over-expression on trophoblast differentiation. TS cells we
their ability to proliferate (A, C) or differentiate into TG cells (B, D), either in th
mean F SEM. Asterisk (*) indicates that control and experimental values are sigMash2 maintains trophoblast TS cell proliferation after
withdrawal from FGF4
To test if ectopic or over-expression of transcription
factors had any effect on TS cell proliferation or differen-
tiation, we transfected Rosa26 TS cells with expression
vectors encoding Hand1, Mash2, Gcm1 and Stra13. TS cells
were plated at very low density to allow analysis of the fate
of individual transfected cells identified by expression of a
co-transfected EGFP reporter. Transfection of TS cells with
an EGFP expression vector alone did not alter the patterns
or rates of TS cell proliferation or differentiation compared
with non-transfected cells (data not shown). Transfection of
TS cells with a Mash2 expression vector had no effect on
the percentage of cells that differentiated to the SynT fate
(data not shown). Likewise, Mash2 over-expression did not
affect the number of cells able to differentiate into TG cells
(Figs. 4B, D), in contrast to previous findings with trans-
fected Rcho-1 cells (Cross et al., 1995; Kraut et al., 1998;
Scott et al., 2000). Mash2-expressing cells that were main-
tained in the presence of FGF4/CM did have a slightly faster
rate of proliferation; however, as assessed by cell clone size
by 48 h after transfection, the difference was not statisticallyre transfected with empty vector or Mash2 expression vector and scored for
e presence (A, B) or absence (C, D) of FGF4/CM. Plotted values represent
nificantly different by t test (P < 0.05).
Fig. 5. Effect of Hand1 over-expression on trophoblast differentiation. TS
cells maintained in FGF4/CM were transfected with empty vector or Hand1
expression vector and scored for their ability to proliferate (A) or
differentiate into TG cells (B). Plotted values represent mean F SEM.
Asterisk (*) indicates that control and experimental values are significantly
different by t test (P < 0.05).
Fig. 6. Effect of Stra13 over-expression on trophoblast differentiation. TS
cells maintained in FGF4/CM were transfected with empty vector or Stra13
expression vector and scored for their ability to proliferate (A) or
differentiate into TG cells (B). Plotted values represent mean F SEM.
Asterisk (*) indicates that control and experimental values are significantly
different by t test (P < 0.05).
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divided only once after FGF4/CM was withdrawn from the
medium, Mash2-transfected cells divided twice (Fig. 4C).
These data suggest that Mash2 can stimulate FGF4-inde-
pendent proliferation of TS cells, although the effect is
transient.
Hand1 and Stra13 promote differentiation of TS cells into
giant cells even in the presence of FGF4
Ectopic expression of Hand1 in TS cells that were
maintained in the presence of FGF4/CM resulted in asignificant increase in the formation of TG cells by 72
h after transfection (Fig. 5B), as well as eventually slowing
cell proliferation (Fig. 5A). In cells where differentiation
was promoted by withdrawal of FGF4/CM, Hand1 over-
expression had no additional effect (data not shown). Over-
expression of Stra13 in TS cells also promoted TG cell
differentiation. However, the effect occurred more rapidly
and was more pronounced than with Hand1 (Fig. 6B).
Stra13 expression promoted a rapid arrest of cell prolifer-
ation, such that transfected cells only divided once within 48
M. Hughes et al. / Developmental Biology 271 (2004) 26–37 33h (Fig. 6A). Notably, over 50% of transfected cells had
become post-mitotic TG cells by 48 h (Fig. 6B). The lesser
effect of Hand1 was not due to a failure in transfection, the
expression cassette or ability of Hand1 to be expressed in
TS cells, as judged by immunostaining for an epitope-
tagged version of the Hand1 protein (data not shown) or
Western blot analysis (Fig. 7). The proportion of TS cells
transfected with Hand1 that were transformed into TG cells
was similar to that observed previously in Rcho-1 cell
transfection experiments (Cross et al., 1995; Kraut et al.,
1998; Scott et al., 2000).
To define Stra13 function within the context of the other
bHLH factors, we tested for interactions among Stra13,
Hand1 and Mash2. We have previously found that the
ability of Hand1 over-expression to promote the differenti-
ation of TG cells in transfected Rcho-1 cells is inhibited by
Mash2 over-expression (Scott et al., 2000), possibly through
either direct or indirect protein interactions (Firulli et al.,
2000; Scott et al., 2000). Rcho-1 cells were therefore co-
transfected with Stra13 andMash2 expression constructs. In
contrast to its effects on Hand1 activity, Mash2 over-
expression did not inhibit Stra13 activity (Fig. 8A). Similar
results were observed in TS cells (Fig. 8B). The Stra13
protein does not appear to act as a heterodimer with Hand1,
as a Hand1–Stra13 interaction has not been detected in
mammalian two-hybrid experiments (data not shown), and
co-transfection of expression vectors for Stra13 and Hand1
did not further stimulate TG cell differentiation (Fig. 8B).Fig. 7. Expression of Hand1 and Stra13 proteins in transfected cells. TS and
COS (used as a positive control) cells were transfected with increasing
amounts of expression vector for FLAG epitope-tagged Hand1 and for
Stra13, harvested 24 h later and subjected to Western blotting.
Fig. 8. Stra13-stimulated TG cell differentiation is not inhibited by Mash2.
Rcho-1 stem cells (A) and TS cells (B) were transfected with either empty
vector, or expression vectors for Hand1, Mash2 and Stra13 either alone or
in combination. TG cell differentiation of transfected cells was scored 48
h later. Scale bars represent mean F SEM. Values with different
superscripts are significantly different (P < 0.05).Gcm1 promotes cell division arrest and blocks giant cell
differentiation
Ectopic expression of Gcm1 in TS cells maintained in the
presence of FGF4/CM resulted in a dramatic arrest of cell
proliferation, such that the cells stopped dividing immedi-
ately and remained as single cell clones (Figs. 9A, B). In
contrast with Hand1- and Stra13-transfected cells, the
Gcm1-transfected cells did not transform into TG cells
and retained a TS-like morphology (Fig. 9B). Indeed, when
Fig. 9. Effect of Gcm1 on proliferation, TG and SynT differentiation. TS cells were transfected with empty vector or Gcm1 expression vector and scored for
their ability to proliferate (A, B) or differentiate into TG cells (C, D), either in the presence (A, B, C) or absence (D) of FGF4/CM. Panel B shows the
morphology of the Gcm1-transfected cells 72 h after transfection, and that they maintain a small, TS cell-like morphology. Plotted values represent mean F
SEM. Asterisk (*) indicates that control and experimental values are significantly different by t test (P < 0.05).
M. Hughes et al. / Developmental Biology 271 (2004) 26–3734compared with controls, the Gcm1-transfected cells differ-
entiated into TG cells at a significantly lower rate (Figs. 9C,
D). Even when TG differentiation was maximally stimulated
by withdrawal of FGF4/CM (up to 50% of cells are TG cells
by 48 h), only approximately 5% of Gcm1-transfected cells
were able to differentiate into TG cells. Over-expression of
Gcm1 had no effect on the rate at which SynT cells formed,
though it should be noted that, due to the rapid arrest of cell
proliferation induced by Gcm1, these cells were only rarely
close enough together to undergo fusion. However, cells
transfected with a vector encoding Gcm1 in an antisense
orientation did show a block to SynT differentiation (Con-
trol: 2.6%; Gcm1 antisense: 0%; chi-square: P < 0.05),
consistent with the phenotype of Gcm1-deficient mice
(Anson-Cartwright et al., 2000).Fig. 10. Model of how the Hand1, Stra13, Mash2 and Gcm1 transcription
factors, and FGF4/CM signaling interact to regulate alternative trophoblast
cell fates.Discussion
The results of the TS cell transfection studies presented
here complement previous work analyzing mouse mutants
to give insights into the functions of Hand1, Mash2, Stra13
and Gcm1 at a cellular level (see Fig. 10). Importantly,
because the ongoing proliferation of TS cells and themaintenance of their stem cell character is dependent on
FGF4 and uncharacterized factors from feeder cells (Tanaka
et al., 1998), we were able to explore the interactions
between these pathways. Withdrawal of FGF4/CM from
TS cells in vitro was associated with rapid up-regulation in
M. Hughes et al. / Developmental Biology 271 (2004) 26–37 35the expression of Hand1, Mash2, Stra13 and Gcm1. Coin-
cident with this, TS cells lost the ability to proliferate and
they terminally differentiated into either TG cells (at a high
rate) or SynT cells (to a more limited extent). The most
important general conclusion is that if Stra13 or Gcm1 (to a
lesser extent Hand1) are ectopically expressed in TS cells
still being stimulated by FGF4/CM, they each have domi-
nant effects in being able to promote cell cycle arrest and
differentiation into either TG cells or SynT.
Whereas Hand1, Stra13 and Gcm1 action is associated
with cell cycle arrest, Mash2 was able to sustain the
proliferation of TS cells after FGF4/CM withdrawal, albeit
only transiently. In vivo, Mash2 mRNA is expressed weakly
in the chorion and more strongly in the ectoplacental cone
and later the SpT. Cells within these regions express mitotic
markers (M.S. and J.C.C., unpublished observations) but,
unlike the chorion, do not express FGFR2, the primary FGF
receptor mediating the FGF4 effect in TS cells of the
chorion (Arman et al., 1998; Tanaka et al., 1998). Therefore,
proliferation within the ectoplacental cone and SpT may be
FGF-independent and based on our experiments, only
transient. These data fit the model that trophoblast cells in
the ectoplacental cone and SpT are a transiently amplifying
‘‘progress zone’’ that serves as an expanded reservoir of
cells that have lost their stem cell potential and are ulti-
mately dedicated to form TG cells. In contrast to findings in
transfected Rcho-1 cells (Cross et al., 1995; Kraut et al.,
1998; Scott et al., 2000), over-expression of Mash2 in TS
cells did not suppress TG cell differentiation. Rcho-1 cells,
which were derived from a trophoblast tumor, grow in an
FGF4-independent manner although they do not express
Mash2 and do not apparently differentiate into any tropho-
blast derivative other than TG cells (Cross et al., 1995; Faria
and Soares, 1991; MacAuley et al., 1998; Soares et al.,
1996). As such, they are poised to only execute the TG
differentiation program. The effect of ectopic Mash2 ex-
pression in Rcho-1 cells may therefore simply be to convert
them to a cell type more like the transiently amplifying
population of TS cells. This fits with the slowly progressive
phenotype of Mash2 mutant mice (Guillemot et al., 1994;
Tanaka et al., 1997).
Previous experiments have shown that Hand1 is both
necessary (Riley et al., 1998; Scott et al., 2000) and
sufficient (Cross et al., 1995; Kraut et al., 1998; Scott et
al., 2000) for promotion of TG cell differentiation. Our
results in transfected TS cells support these conclusions. We
found that another bHLH factor gene, Stra13, also promotes
TG cell differentiation. Stra13 expression is inducible by
retinoic acid (Boudjelal et al., 1997), which has been shown
to also induce TG differentiation (Yan et al., 2001). Al-
though both Stra13 and Hand1 mRNAs are detected in TG
cells, their expression actually begins in precursor cells (this
study; Cross et al., 1995; Scott et al., 2000). Similarly,
during differentiation of TS cells in culture, the Stra13 and
Hand1 mRNAs were detected several days before the onset
of expression of the giant cell-specific gene Pl1. Expressionwas not detected in undifferentiated TS cells, but ectopic
expression of either Hand1 or Stra13 was sufficient to
stimulate TG cell differentiation. Notably, if TG cell differ-
entiation was stimulated by withdrawal of FGF4/CM from
the cultures, over-expression of either Hand1 or Stra13 had
no additional effect, implying that both factors act primarily
to promote mitotic cell cycle exit and poise the cells to
endoreduplicate. The effects of Hand1 and Stra13 were
distinct in that Stra13 had a much more dramatic and rapid
effect both in arrest of cell proliferation and in stimulation of
TG differentiation. This difference in results may be be-
cause, whereas Hand1 action can be interrupted by Mash2
(Scott et al., 2000), the Stra13 effects were not. The effect of
Mash2 on Hand1 is likely due to either direct or indirect
interactions affecting DNA binding (Firulli et al., 2000;
Scott et al., 2000). Stra13 has been shown to dimerize in
vitro with E47 and Mash1, as well as form homodimers
(Boudjelal et al., 1997; St-Pierre et al., 2002), similar to the
types of possible interactions for Hand1 (Firulli et al., 2000,
2003; Scott et al., 2000). However, the difference in
behavior of Hand1 and Stra13 in response to Mash2 implies
that the dimerization characteristics of the Hand1 and Stra13
proteins are different in vivo.
Gcm1 mRNA is expressed in a subset of trophoblast cells
at the chorioallantoic interface at embryonic day 8.5 in mice
that corresponds to sites where morphogenesis begins
(Anson-Cartwright et al., 2000; Basyuk et al., 1999). The
placentas in Gcm1-deficient embryos show a defect in both
chorioallantoic morphogenesis and SynT cell differentiation
(Anson-Cartwright et al., 2000). Our experiments here
showed that expression of antisense Gcm1 RNA blocked
SynT differentiation, without affecting cell proliferation or
TG differentiation. This indicates that the absence of SynT
cells in the Gcm1 mutants is a primary phenotype and not
simply secondary to the morphogenetic defect. The first step
in SynT formation is exit of cells from the mitotic cell cycle
and, therefore, the effect of Gcm1 mutation may simply be
to prevent cell cycle exit, a possibility supported by the
ability of ectopic Gcm1 expression to arrest TS cell prolif-
eration. Gcm1 also appears to regulate the fusogenic process
(Yu et al., 2002). The other major effect of ectopic Gcm1
expression was to restrict the ability of the cells to form TG
cells. The fundamental decision of a TS cell to remain as a
stem cell, or to progress towards the alternative fates of TG
and SynT cells is therefore regulated, rather simply, by
regulated expression of Gcm1.
The striking effects of Hand1, Stra13 and particularly
Gcm1 on suppressing TS cell proliferation raise two inter-
esting issues. First, it will be interesting to understand at a
molecular level how Hand1, Stra13 and Gcm1 modify the
responses of the cells to FGF4/CM. One possibility is that
these transcription factors directly suppress the signaling
ability of FGF4/CM by altering expression of a signaling
component. Withdrawal of FGF4/CM from the culture
medium results in cell proliferation arrest that takes about
2 days to complete. This is similar to the time frame for the
M. Hughes et al. / Developmental Biology 271 (2004) 26–3736effects of Hand1 and Stra13. Stra13 is associated with arrest
of cell proliferation in other systems (Sun and Taneja,
2000). Notably though, Gcm1 has a much more rapid effect
in that ectopic expression results in immediate cell prolifer-
ation arrest. Therefore, it is likely that Gcm1 has an effect on
cell proliferation that is more than simply shutting off FGF4/
CM signaling. Induction of a cyclin-dependent kinase
inhibitor is one possibility. The second issue concerns the
importance of regulated expression of the Hand1, Stra13
and Gcm1 genes for normal trophoblast development. None
of these factors are widely expressed in the chorion and the
implication of the antiproliferative effects is that suppressing
their expression within the chorion is actually rather critical
for maintenance of the TS cell phenotype.Acknowledgments
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